HIMSNYSEHealthcare
Hims & Hers Health (HIMS) seasonality
Hims & Hers Health, Inc. (HIMS) seasonality: across 6 complete years (2020–2025), HIMS's strongest month has been November (average +21.8%, higher in 4 of 6 years) and its weakest August (average −14.6%, higher in 2 of 6 years). Over the 20 trading sessions after , it rose in 5 of 6 past years, with an average move of +9.8%. Data through . Historical averages, not a forecast.
Historical averages from daily closing prices, not a forecast and not investment advice. Disclaimer · Methodology
HIMS seasonality at a glance
| Month | Average | Median | Years higher | Best year | Worst year |
|---|---|---|---|---|---|
| January | +14.3% | +15.3% | 4 of 6 (67%) | +54.2% (2025) | −25.5% (2022) |
| February | +15.4% | +14.0% | 4 of 6 (67%) | +52.0% (2024) | −23.3% (2021) |
| March | −5.9% | −4.8% | 2 of 6 (33%) | +18.6% (2024) | −34.5% (2025) |
| April | −3.0% | −3.4% | 2 of 6 (33%) | +16.8% (2023) | −21.0% (2022) |
| May | +19.2% | +8.0% | 3 of 6 (50%) | +70.9% (2025) | −22.9% (2023) |
| June | −2.1% | +3.2% | 4 of 6 (67%) | +12.1% (2022) | −24.4% (2021) |
| July | +7.3% | +3.2% | 4 of 6 (67%) | +36.6% (2022) | −27.4% (2021) |
| August Worst | −14.6% | −12.8% | 2 of 6 (33%) | +2.7% (2022) | −36.0% (2025) |
| September | +8.0% | +3.9% | 3 of 6 (50%) | +33.9% (2025) | −12.3% (2022) |
| October | −8.5% | −9.1% | 2 of 6 (33%) | +3.4% (2021) | −19.9% (2025) |
| November Best Now | +21.8% | +19.7% | 4 of 6 (67%) | +71.1% (2024) | −16.0% (2021) |
| December | −0.1% | +0.1% | 3 of 6 (50%) | +38.8% (2020) | −25.0% (2024) |
Current seasonal picture · November 13, 2026
As of November 13, 2026, Hims & Hers Health, Inc. is −39.2% year to date. Across 6 complete years (2020–2025), the average at this point of the year was +35.1%, so HIMS is running behind its seasonal average by 74.3 percentage points. A year ago on the same date it was +49.1% year to date.
Over the next 20 trading days (about four weeks) from this date, HIMS historically averaged +9.8% (median +14.8%) and rose in 5 of 6 years (83%). Best: +23.3% in 2020; worst: −20.4% in 2021. For comparison, SPY (the S&P 500) averaged +1.3% over the same window, up in 23 of 32 years, so HIMS's seasonal edge over the market for this window is +8.5%.
In the last 18 sessions, HIMS moved in the same direction as its seasonal average on 9 of 18 days (50%), close to the 50% you would expect by chance.
Within the next 60 days, the historically strongest 10-session window began around November 20 (average +15.0%, up in 5 of 6 years) and the weakest around December 8 (average −5.3%, up in 1 of 6 years).
Calculated from daily closing prices (compounded, excluding dividends) for complete calendar years. Past patterns do not predict future results; this is not investment advice.
Next trading week (Monday to Friday): will HIMS close up, flat or down?
A free poll for fun and research: no stakes, no prizes, not advice. One vote per person per week; you can change it until the week starts. Results are scored from closing prices after the week ends. All results · My calls
HIMS seasonal charts
Seasonality by calendar date
Each line is one calendar year of Hims & Hers Health, Inc., measured as its return since the previous year's final close (year to date) and drawn on a common January-to-December axis. The bold average line shows where HIMS has typically stood on each date across every complete year on file.
How the average is built. Returns are compounded from daily closing prices. Every year counts on every date: on weekends and market holidays a year keeps its last close, so the average is never built from a different mix of years on different days. Only complete calendar years enter the average, so a partial current year or a mid-year listing cannot distort it. This view surfaces date-anchored effects such as tax-loss selling into December, the January effect, quarter-end rebalancing and recurring earnings seasons.
Day-of-year seasonality for HIMS
The bold blue line is the multi-year average and orange is the current year; thinner coloured lines are the most recent years, and older years appear in grey when you choose All years. When the current-year line sits above the average, HIMS is ahead of its usual pace for the date. Hover any point to compare each year with the average on that day.
What the data says now · November 13, 2026
As of November 13, 2026, Hims & Hers Health, Inc. is −39.2% year to date. Across 6 complete years (2020–2025), the average at this point of the year was +35.1%, so HIMS is running behind its seasonal average by 74.3 percentage points. A year ago on the same date it was +49.1% year to date.
This year's path so far has a correlation of 0.04 with the seasonal average (1 would be a perfect match, 0 no relationship), so this year has not followed the typical seasonal shape.
The past years whose path most resembled 2026 up to this date: 2020 (next 20 sessions: +23.3%), 2024 (next 20 sessions: +9.0%), 2022 (next 20 sessions: +23.2%).
Calculated from daily closing prices (compounded, excluding dividends) for complete calendar years. Past patterns do not predict future results; this is not investment advice.
Seasonality by week and weekday
Here each session is placed by its week number and weekday instead of its date. Weeks run Sunday to Saturday and week 1 is the week that contains January 1. Because calendar dates shift by a day or two each year, week numbers line up comparable sessions: week 14 ran from Monday, April 1 to Friday, April 5 in 2024, from March 31 to April 4 in 2025 and from March 30 to April 3 in 2026. Comparing "week 14, Monday" across years therefore compares the first Monday of the second quarter each time, which a fixed date such as April 1 cannot do.
Use this view for weekday tendencies (soft Mondays, strong Fridays) and to see how a pattern drifts week by week through the year. Each point is the year-to-date return at that week and weekday, averaged across complete years.
Year-to-date path by week number and weekday
Each line is one year building through the weeks; the bold line is the average. Where the yearly lines bunch together, the pattern repeated year after year; where they fan out, that stretch of the calendar was driven by events rather than the season. Labels read "week - weekday", for example "14 - Mon".
What the data says now · November 13, 2026
Over the last ten years, HIMS's strongest weekday was Monday (average +0.78%, up on 55% of Mondays) and its weakest was Thursday (−0.17%, up on 44%). Differences this small are easily swamped by news, so read them as tendencies, not rules.
For the coming week (the next 5 sessions from November 13, 2026), HIMS historically averaged −3.1% and rose in 2 of 6 years.
In the last 8 completed weeks, the weekly move matched the direction of the seasonal average in 3 of 8.
Calculated from daily closing prices (compounded, excluding dividends) for complete calendar years. Past patterns do not predict future results; this is not investment advice.
Seasonality by trading day of the month
Sessions are numbered by their position inside each month: trading day 1 is the first session of the month, day 2 the second, whatever the calendar date. Most months have 19 to 23 sessions. Lining months up this way exposes flow-driven effects that calendar dates blur, such as pension and payroll inflows around the turn of the month, mid-month options expiry and fund rebalancing in the final sessions.
The chart runs from the first trading day of January to the last trading day of December, so each point is the year-to-date return after that session. On the axis, trading day N of a month is drawn at day N of that month.
Year-to-date path by trading day of the month for HIMS
Steps that recur at the same point of every month, a rise over the first few sessions or a dip before month-end, are the signature of flows rather than news. Compare the slope of the average around the start and end of each month with the middle weeks.
What the data says now · November 13, 2026
After 10 trading days of November, HIMS is −28.7% month to date. At the same point of November in past years it averaged +7.0% (median +5.1%, up in 3 of 6 years).
Turn of the month: over the last ten years, the last two and first three trading days of each month averaged +0.39% per day, versus +0.14% on the other days, the classic month-end inflow pattern.
Calculated from daily closing prices (compounded, excluding dividends) for complete calendar years. Past patterns do not predict future results; this is not investment advice.
HIMS seasonality vs the S&P 500
HIMS seasonality compared with the S&P 500 (SPY)
Both lines are average year-to-date returns over the same complete years, so the comparison is like for like. The dashed line is the gap: when it rises, HIMS has typically outperformed the market over that stretch of the calendar; when it falls, it has typically lagged. A stock with a strong seasonal line can still trail the market if SPY rises even more in the same weeks.
Measured over the same 6 complete years (2020–2025), HIMS's average calendar year ended +39.2% against +14.6% for SPY. The month in which HIMS typically gained most on the market was Nov (+26.7% relative), and the month it typically lost most ground was Aug (−35.5%).
Show the numbers
| End of | HIMS | SPY | Gap |
|---|---|---|---|
| Jan | +14.3% | +0.7% | +13.6% |
| Feb | +32.2% | −0.5% | +32.6% |
| Mar | +20.6% | −1.0% | +21.7% |
| Apr | +18.0% | −0.4% | +18.4% |
| May | +42.0% | +2.4% | +39.6% |
| Jun | +37.7% | +4.3% | +33.4% |
| Jul | +50.8% | +8.2% | +42.7% |
| Aug | +17.0% | +9.8% | +7.2% |
| Sep | +32.5% | +6.7% | +25.8% |
| Oct | +19.8% | +8.5% | +11.3% |
| Nov | +51.8% | +13.8% | +38.0% |
| Dec | +39.2% | +14.6% | +24.6% |
Calendar date vs week and weekday vs trading day of the month
The averages from methods 1, 2 and 3 above, placed on one calendar axis (week slots and trading days are drawn on the dates they fell on in 2021). Lines that overlap mean the seasonal pattern holds however you count the sessions; a gap shows where an effect depends on the counting, typically around month ends and holidays.
All three methods measure the same thing, the average year-to-date return across 6 complete years, but line the sessions up differently. For HIMS they diverge noticeably at times: the largest gap between them is 16.4 percentage points around February 19. Where the lines separate, the effect depends on how you count (by date, by weekday or by session of the month); where they overlap, the pattern is robust to the method.
Show the numbers
| End of | Calendar date | Week & weekday | Trading day |
|---|---|---|---|
| Jan | +14.3% | +12.4% | +14.3% |
| Feb | +32.2% | +29.6% | +31.6% |
| Mar | +20.6% | +21.4% | +20.6% |
| Apr | +18.0% | +22.2% | +18.0% |
| May | +42.0% | +44.4% | +43.7% |
| Jun | +37.7% | +35.6% | +37.7% |
| Jul | +50.8% | +39.4% | +50.8% |
| Aug | +17.0% | +16.7% | +17.4% |
| Sep | +32.5% | +29.4% | +32.5% |
| Oct | +19.8% | +23.8% | +26.2% |
| Nov | +51.8% | +48.9% | +51.8% |
| Dec | +39.2% | +39.2% | +39.2% |
HIMS monthly returns heatmaps
Intraday momentum. Each cell sums the daily open-to-close percent changes inside that month, leaving out the overnight gaps between one close and the next open. Compare it with the next heatmap to see whether a month's gains came during trading hours or overnight. Very old years can show 0.00 where the data source recorded a single price per day.
Held through the month. Each cell is the change from the first session open to the last session close — the return of entering on day one and exiting on the final bar.
HIMS earnings, revenue and company events
Earnings reaction history · 24 reports since Mar 2021
On the first trading session after its earnings releases, HIMS closed higher 8 of 24 times (33%), with a typical move of ±10.4%. Average reaction by fiscal quarter: Q1 −1.4% (up 2 of 6) · Q2 −3.6% (up 1 of 6) · Q3 +1.0% (up 2 of 6) · Q4 +4.8% (up 3 of 6).
Across 23 reports with full windows, the stock moved −3.9% on average in the 15 sessions before the report and +5.7% in the 15 sessions after the reaction day.
The latest report was released on November 9, 2026 (after the close) for fiscal Q3 2026; the stock moved −16.61% on the reaction day.
Report dates and actual EPS come from the company's SEC filings; price moves from daily closes. Analyst estimates are not shown. Past reactions do not predict the next one.
Post-earnings price move: the last 12 reports and the average
0 is the first session after the release; each line is the change from the close before it. Thin lines are single reports, coloured by fiscal quarter (solid = latest, dashed = a year earlier, dotted = two years earlier); the thick line is the average of all reports. Use the buttons to switch to averages by quarter, or click any legend item.
| Released | Timing | Fiscal quarter | EPS (diluted) | EPS vs year ago | Reaction day | 15 sessions before | 15 sessions after |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | After close | Q3 2026 | $-0.14 | −333% | −16.61% | −18.5% | – |
| Aug 10, 2026 | After close | Q2 2026 | $-0.37 | −318% | −3.97% | −2.8% | −6.8% |
| May 11, 2026 | After close | Q1 2026 | $-0.40 | −300% | −14.10% | −6.0% | +9.9% |
| Feb 23, 2026 | After close | Q4 2025 | $0.08* | – | −0.32% | −42.8% | +61.6% |
| Nov 3, 2025 | After close | Q3 2025 | $0.06 | −81% | −3.60% | −18.9% | −13.3% |
| Aug 4, 2025 | After close | Q2 2025 | $0.17 | +183% | −12.36% | +21.8% | −18.3% |
| May 5, 2025 | After close | Q1 2025 | $0.20 | +300% | +18.12% | +53.8% | +7.8% |
| Feb 24, 2025 | After close | Q4 2024 | $0.10* | – | −22.32% | +37.6% | −21.0% |
| Nov 4, 2024 | After close | Q3 2024 | $0.32 | – | −0.58% | +1.3% | +48.6% |
| Aug 5, 2024 | After close | Q2 2024 | $0.06 | – | −5.38% | −21.9% | −12.1% |
| May 6, 2024 | After close | Q1 2024 | $0.05 | – | +6.01% | −11.9% | +58.5% |
| Feb 26, 2024 | After close | Q4 2023 | $0.01* | – | +31.02% | +15.6% | +16.5% |
| Nov 6, 2023 | After close | Q3 2023 | $-0.04 | – | +10.99% | 0.0% | +25.0% |
| Aug 7, 2023 | After close | Q2 2023 | $-0.03 | – | −5.82% | −13.4% | −6.7% |
| May 8, 2023 | After close | Q1 2023 | $-0.05 | – | −10.13% | +18.9% | −16.1% |
| Feb 27, 2023 | After close | Q4 2022 | $-0.05* | – | +16.79% | +22.3% | −11.0% |
| Nov 7, 2022 | After close | Q3 2022 | $-0.09 | – | +19.70% | +6.5% | +11.9% |
| Aug 8, 2022 | After close | Q2 2022 | $-0.10 | – | −5.10% | +20.8% | −1.3% |
| May 9, 2022 | After close | Q1 2022 | $-0.08 | – | −6.47% | −23.2% | +16.1% |
| Feb 22, 2022 | After close | Q4 2021 | $-0.11* | – | +13.10% | −13.9% | −4.0% |
| Nov 10, 2021 | After close | Q3 2021 | $-0.08 | – | −3.99% | −3.4% | −23.6% |
| Aug 11, 2021 | After close | Q2 2021 | $-0.05 | – | +10.83% | −14.4% | −0.6% |
| May 4, 2021 | Before open | Q1 2021 | $-0.34 | – | −1.72% | −7.0% | +1.8% |
| Mar 18, 2021 | After close | Q4 2020 | $-0.15* | – | −9.74% | +6.6% | −13.4% |
* Q4 EPS derived from the annual figure minus the first three quarters. EPS as reported by the company; not adjusted for later stock splits.
Where the revenue comes from · as reported to the SEC
HIMS reports its revenue by 2 regions. Latest: $890M in the quarter ending Sep 2026, +49% from a year earlier.
Figures are from HIMS’s own 10-Q and 10-K financial statements (XBRL), as reported, not adjusted. Products, segments and regions are the company’s own groupings and can change when it reorganises; only periods comparable with the latest are shown. * Fourth quarter = fiscal year minus the first nine months.
HIMS revenue by region
In the quarter ending Sep 2026, United States brought in $657M, 74% of HIMS’s $890M revenue. Compared with a year earlier, Outside the U.S. changed +321% and United States +21%.
| Quarter ending | Mar ’25 | Jun ’25 | Sep ’25 | Dec ’25* | Mar ’26 | Jun ’26 | Sep ’26 | Share | vs year before |
|---|---|---|---|---|---|---|---|---|---|
| United States | $579M | $537M | $544M | $554M | $530M | $622M | $657M | 74% | +21% |
| Outside the U.S. | $7M | $8M | $55M | $64M | $78M | $131M | $233M | 26% | +321% |
| Total revenue | $586M | $545M | $599M | $618M | $608M | $753M | $890M | 100% | +49% |
Fiscal years
| Fiscal year ending | Dec ’23 | Dec ’24 | Dec ’25 | Share | vs year before |
|---|---|---|---|---|---|
| United States | $854M | $1.4B | $2.2B | 94% | +53% |
| Outside the U.S. | $18M | $27M | $134M | 6% | +399% |
| Total revenue | $872M | $1.5B | $2.3B | 100% | +59% |
Company events · from 48 SEC 8-K filings since 2019
In the last five years HIMS filed 31 event reports, including 6 deals, 12 leadership. Latest major event: completed an acquisition or sale of assets on January 26, 2021 (−11.3% the next session).
From the item codes companies must use when filing a Form 8-K with the SEC. Under each event type is a one-line extract of what the filing says, picked out of the filing text automatically (not written or checked by an editor); open the filing for the full wording. Quarterly earnings releases are in the section above.
| Filed | Event | Next-session move | Source |
|---|---|---|---|
| Executive or board changeThe board of directors of Hims & Hers Health, Inc. increased the size of the Board from nine to ten directors and appointed Dr. Andrew Huberman, 51, to fill the newly created directorship, effective immediately. | −16.61% | SEC filing | |
| Executive or board changeJonathan M. Franklin commenced employment with Hims & Hers Health, Inc. as chief accounting officer. On October 7, 2026, the Company's board of directors appointed Mr. Franklin as principal accounting officer of the Company, effective… | −5.01% | SEC filing | |
| Executive or board changeIrene Becklund informed Hims & Hers Health, Inc. of her intention to resign as Chief Accounting Officer and Principal Accounting Officer, effective as of October 9, 2026. | −0.43% | SEC filing | |
| Signed a material agreement · New debt or financingXeCare LLC and Apostrophe Pharmacy LLC, subsidiaries of Hims & Hers Health, Inc., entered into a Master Receivables Purchase Agreement with JPMorgan Chase Bank, N.A., as purchaser. | −2.05% | SEC filing | |
| Shareholder vote resultsHims & Hers Health, Inc. held its Annual Meeting of Stockholders. At the Annual Meeting, the Company’s stockholders voted on three proposals, each of which is described in more detail in the Company’s definitive proxy statement on… | +4.31% | SEC filing | |
| Signed a material agreement · New debt or financing · Other company newsHims & Hers Health, Inc., as borrower, entered into Amendment No. 3 to the Revolving Credit and Guaranty Agreement, dated as of February 18, 2025, by among the Company, the subsidiary borrowers and the guarantors from time to time party… | −0.90% | SEC filing | |
| Signed a material agreement · New debt or financing · Unregistered sale of sharesThe Company issued $402.5 million aggregate principal amount of Notes. The Notes were issued pursuant to, and are governed by, an indenture, dated as of May 21, 2026, between the Company and U.S. Bank Trust Company, National Association… | −1.08% | SEC filing | |
| Other company newsAnnounced the pricing of its private offering of 0.00% Convertible Senior Notes due 2032 to qualified institutional buyers pursuant to Rule 144A under the Securities Act. | +0.67% | SEC filing | |
| Investor presentation or announcementAnnounced a strategic shift for the U.S. weight loss business. | −7.88% | SEC filing | |
| Signed a material agreement · Unregistered sale of shares · Investor presentation or announcementHims & Hers Health, Inc., Hims, Inc., and Horizon BidCo Pty Ltd ACN 694 778 375, an Australian proprietary company and wholly-owned subsidiary of the Company, entered into a Securities Sale Deed with the sellers party thereto, pursuant… | −0.13% | SEC filing | |
| Other company newsThe Board of Directors of Hims & Hers Health, Inc. authorized and approved a new share repurchase program pursuant to which the Company may repurchase up to $250.0 million of its Class A common stock. | −3.79% | SEC filing | |
| Executive or board changeNader Kabbani, the Chief Operating Officer of Hims & Hers Health, Inc. determined to step into a new advisory role for the Company effective November 2, 2025, where he will continue to provide ongoing strategic guidance to the Company… | −9.21% | SEC filing | |
| Other company newsInvestors of Hims & Hers Health, Inc. and others should note that we announce information to the public about the Company, the products and services available on the Company’s platform, and other updates regarding the Company through a… | −2.95% | SEC filing | |
| Signed a material agreementHims, Inc., a wholly-owned subsidiary of Hims & Hers Health, Inc. entered into a lease agreement with Mendel New Albany Property Owner LLC for the lease of approximately 352,012 square feet of space located at 9885 Innovation Campus Way… | +2.54% | SEC filing | |
| Shareholder vote resultsHims & Hers Health, Inc. held its Annual Meeting of Stockholders. At the Annual Meeting, the Company’s stockholders voted on three proposals, each of which is described in more detail in the Company’s definitive proxy statement on… | +3.09% | SEC filing | |
| Signed a material agreement · New debt or financing · Unregistered sale of sharesThe Company issued $1.0 billion aggregate principal amount of Notes. The Notes were issued pursuant to, and are governed by, an indenture, dated as of May 13, 2025, between the Company and U.S. Bank Trust Company, National Association… | −4.50% | SEC filing | |
| Other company newsAnnounced the pricing of its private offering of 0.00% Convertible Senior Notes due 2030 to qualified institutional buyers pursuant to Rule 144A under the Securities Act. | +1.09% | SEC filing | |
| Executive or board changeAnnounced her intention to transition into an advisory role with Hims & Hers in the coming months. The effective date of Ms. Baird’s departure has not yet been determined. | −1.90% | SEC filing | |
| Executive or board changeIncreased the size of the Board from nine to ten directors and appointed Deb Autor, 57, to fill the newly created vacancy, effective immediately. | +4.89% | SEC filing | |
| Other company newsHims & Hers Health, Inc. filed a prospectus supplement dated September 9, 2024, which forms part of the Company’s automatic “shelf” Registration Statement on Form S-3 (File No. 333-282008), which was filed on September 9, 2024 with the… | +4.01% | SEC filing | |
| Executive or board changeIncreased the size of the Board from eight to nine directors and appointed Kåre Schultz, 63, to fill the newly created vacancy, effective immediately. | +11.95% | SEC filing | |
| Shareholder vote resultsHims & Hers Health, Inc. held its Annual Meeting of Stockholders. At the Annual Meeting, the Company’s stockholders voted on three proposals, each of which is described in more detail in the Company’s definitive proxy statement on… | +1.94% | SEC filing | |
| Executive or board changeIncreased the size of the Board from ten to eleven directors and appointed Anja Manuel, 49, to fill the newly created vacancy, effective immediately. | +1.87% | SEC filing | |
| Executive or board changeIncreased the size of the Board from nine to ten directors and appointed Christopher Payne, 55, to fill the newly created vacancy, effective March 30, 2024. | −5.35% | SEC filing | |
| Shareholder vote results | −0.11% | SEC filing | |
| Executive or board change | +1.35% | SEC filing | |
| Shareholder vote results | −6.67% | SEC filing | |
| Investor presentation or announcement | +3.68% | SEC filing | |
| Other company news | +4.95% | SEC filing | |
| Executive or board change | −0.62% | SEC filing | |
| Executive or board change | −1.35% | SEC filing | |
| Executive or board change · Investor presentation or announcement | +4.75% | SEC filing | |
| Other company news | +4.45% | SEC filing | |
| Investor presentation or announcement | −3.33% | SEC filing | |
| Shareholder vote results | +2.02% | SEC filing | |
| Results update | +4.19% | SEC filing | |
| Executive or board change | +13.54% | SEC filing | |
| Completed an acquisition or sale of assets · Auditor change · Change in control · Signed a material agreement · Change to shareholder rights · Executive or board change · Unregistered sale of shares | −11.32% | SEC filing | |
| Shareholder vote results | −3.19% | SEC filing | |
| Other company news | −6.21% | SEC filing | |
| Other company news | −0.86% | SEC filing | |
| Investor presentation or announcement | +1.40% | SEC filing | |
| Investor presentation or announcement | −0.10% | SEC filing | |
| Investor presentation or announcement | +0.20% | SEC filing | |
| Investor presentation or announcement | +1.39% | SEC filing | |
| Investor presentation or announcement | −2.69% | SEC filing | |
| Signed a material agreement · Unregistered sale of shares · Investor presentation or announcement | −8.09% | SEC filing | |
| Executive or board change | −0.10% | SEC filing |
HIMS price history and multi-year cycles
Daily percent change, September 13, 2019 to November 13, 2026
Close is plotted by default. Add open, high, low or volume from the legend, and drag across the chart to zoom into any period.
What if you had traded HIMS by simple rules?
$10,000 in HIMS · January 2023 to Nov 13, 2026
Trading hours vs overnight
More of HIMS's gains came during trading hours: owning it only from open to close turned $10,000 into $36,758, owning it only from close to the next open into $8,258. Together they make up buy and hold ($31,218).
Did the seasonal signal help? Picked worse days
Average open-to-close move: −1.618% on the 18 days when all three methods pointed up, +0.240% on all days, −0.683% on the 14 down-signal days. Holding from the previous close to the next open: −3.43% around up-signal days vs +0.31% on any day.
Hypothetical results from daily open and close prices since January 2023 (earlier prices are rounded too coarsely for open-based tests), price only: dividends are not added back, and because a stock drops by its dividend at the open on the ex-dividend date, overnight results of dividend payers are understated by roughly their dividend yield; no taxes. The "after costs" column deducts 0.05% per trade; real spreads, commissions and slippage can be larger, which matters most for daily rules. Seasonal signals use only data from years before each trade. Past results do not predict future results. Study: these rules across 293 stocks and ETFs.
| Rule | $10,000 became | Per year | Last 10 yrs, per year | Trades | Winning trades | Average trade | Worst drawdown | After 0.05% per trade |
|---|---|---|---|---|---|---|---|---|
| Open to close, every dayBuy at each open, sell at the same day's close (trading hours only) | $36,758 | +40.1% | +14.2% | 971 | 49% | +0.24% | −81% | $22,618 |
| Close to next open, every dayBuy at each close, sell at the next open (overnight only) | $8,258 | −4.8% | −2.0% | 970 | 50% | +0.04% | −72% | $5,084 |
| Open to next openBuy at the open, sell at the next session's open | $30,277 | +33.2% | +11.9% | 970 | 50% | +0.27% | −78% | $18,639 |
| Close to close (buy and hold)Buy at the close, sell at the next close: the same as holding | $31,218 | +34.3% | +11.6% | 970 | 50% | +0.27% | −79% | $19,219 |
| Each week, open to closeBuy the week's first open, sell its last close (out over weekends) | $18,347 | +17.0% | +6.9% | 202 | 47% | +0.89% | −76% | $16,584 |
| Each month, open to closeBuy the month's first open, sell its last close | $28,919 | +31.7% | +8.5% | 47 | 51% | +6.22% | −77% | $28,247 |
| Each year, open to closeBuy the year's first open, sell its last close | $49,558 | +51.4% | +13.7% | 3 | 100% | +81.14% | 0% | $49,484 |
| Up-signal days, open to closeOn each day when all three seasonal methods point up: buy at that day's open, sell at its close. Otherwise in cash. | $7,307 | −7.8% | −2.8% | 18 | 33% | −1.62% | −32% | $7,241 |
| Up-signal days, close before to open afterBuy at the close the day before an up-signal day, sell at the open the day after it. Back-to-back signal days are held as one trade. | $5,411 | −14.7% | −5.5% | 14 | 29% | −4.13% | −47% | $5,373 |
| Hold, but sit out down-signal daysHold all the time, except: sell at the close before a day when all three methods point down, stay in cash through that day (and any down days right after it), buy back at the close of the last one. | $42,001 | +45.0% | +14.9% | 13 | 46% | +42.25% | −79% | $41,729 |
Growth of $10,000 under each rule (log scale)
Each line is the value of $10,000 following one rule from January 2023. On a log scale, equal slopes mean equal percentage growth. Click the legend to add the weekly, monthly and other seasonal rules.
| Day type | Days | Open to close | Up days | Previous close to next open | Up |
|---|---|---|---|---|---|
| All three methods up | 18 | −1.618% | 33% | −3.43% | 28% |
| All three methods down | 14 | −0.683% | 50% | −2.00% | 38% |
| All days | 971 | +0.240% | 49% | +0.31% | 50% |
HIMS seasonality data tables
Updated This HIMS seasonality chart is built from 1,738 trading days of historical data, spanning from through — covering 8 years of market activity.
Sessions traded per month for HIMS. Months with more sessions carry more weight in every seasonal average below.
Year-by-year performance for Hims & Hers Health, Inc., so a seasonal pattern can be read against the trend it sits inside.
How to read this HIMS seasonality page
HIMS seasonality FAQ
What is the best month for HIMS stock?
Historically November: across 6 complete years (2020–2025) HIMS averaged +21.8% in November and finished the month higher in 4 of 6 years. Its weakest month has been August (average −14.6%, higher in 2 of 6 years).
How has HIMS performed in the next four weeks historically?
In the 20 trading sessions after November 13, HIMS rose in 5 of 6 past years, with an average move of +9.8% and a median of +14.8%. This is a historical record, not a forecast.
What is HIMS seasonality?
Seasonality is the tendency of a stock or fund to behave differently at particular points of the calendar. This page measures it for Hims & Hers Health, Inc. three ways (by calendar date, by week and weekday, and by trading day of the month) across 1,738 trading sessions.
How are the seasonal averages calculated?
From daily closing prices, compounded rather than added, so a 10% gain followed by a 10% loss counts as the 1% loss it really is. Each year's year-to-date return is carried over weekends and holidays, and only complete calendar years enter the averages. Prices are adjusted for splits but not for dividends.
Why do the three seasonality methods sometimes disagree?
They line the data up differently. A calendar date falls on a different weekday and a different trading day of the month every year, so an effect driven by month-end flows shows clearly by trading day and only faintly by date. Agreement across all three is the stronger signal.
How current is the data?
Prices are refreshed automatically after each trading session and checked for gaps, duplicates, bad prints and unadjusted splits. The latest session on file is November 13, 2026.
Can seasonality be traded on its own?
No. These are historical averages over a limited number of years, and any single year can differ completely. Treat a seasonal pattern as context for a decision you have other reasons to make, and read the disclaimer.
Full method: how SeasonalityCharts measures seasonality · Disclaimer
Data last refreshed November 13, 2026. Seasonality figures are historical averages drawn from 1,738 trading sessions; they are not a forecast, and nothing on this page is investment advice. Please do your own research and see the Disclaimer.
